173 related articles for article (PubMed ID: 1159680)
1. (4-Phenylalanine)oxytocin, an inhibitor of the antidiuretic effect of 8-arginine-vasopressin.
Nestor JJ; Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1022-4. PubMed ID: 1159680
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological properties of [1-L-penicillamine,4-L-leucine]oxytocin.
Ferger MF; Chan WY
J Med Chem; 1975 Oct; 18(10):1020-2. PubMed ID: 1159679
[TBL] [Abstract][Full Text] [Related]
3. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
Lundell EO; Ferger MF
J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
[TBL] [Abstract][Full Text] [Related]
4. [1-Deaminopenicillamine,4-threonine]oxytocin, a potent inhibitor of oxytocin.
Manning M; Lowbridge J; Seto J; Haldar J; Sawyer WH
J Med Chem; 1978 Feb; 21(2):179-82. PubMed ID: 621712
[TBL] [Abstract][Full Text] [Related]
5. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
Nestor JJ; Ferger MF; du Vigneaud V
J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and some pharmacological properties of [1-beta-mercapto-beta,beta-diethylpropionic acid,2-(3,5-dibromo-L-tyrosine)]oxytocin.
Lundell EO; Smith CW; Ferger MF
J Med Chem; 1975 Dec; 18(12):1262-4. PubMed ID: 1195281
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and some pharmacological properties of (3-beta-(2-thienyl)-L-alanine)-8-lysine-vasopressin.
Smith CW; Ferger MF; Chan WY
J Med Chem; 1975 Aug; 18(8):822-5. PubMed ID: 1171984
[TBL] [Abstract][Full Text] [Related]
8. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
[TBL] [Abstract][Full Text] [Related]
9. Potent antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-D- phenylalanine,4-valine]arginine-vasopressin at position 4.
Manning M; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1983 Nov; 26(11):1607-13. PubMed ID: 6631916
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin.
Smith CW; Skala G; Walter R
J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140
[TBL] [Abstract][Full Text] [Related]
11. An investigation of the natriuretic, antidiuretic and oxytocic actions of neurohypophysial hormones and related peptides: delineation of separate mechanisms of action and assessment of molecular requirements.
Chan WY
J Pharmacol Exp Ther; 1976 Mar; 196(3):746-57. PubMed ID: 1263121
[TBL] [Abstract][Full Text] [Related]
12. N-Acetyl-[2-(O-methyl)tyrosine]arginine-vasopressin, an interesting antagonist of the vasopressor response to vasopressin.
Jones DA; Sawyer WH
J Med Chem; 1980 Jun; 23(6):696-8. PubMed ID: 7392038
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and some pharmacological properties of five analogs of oxytocin having L-homocysteine in position 6.
Smith CW; Ferger MF
J Med Chem; 1976 Feb; 19(2):250-4. PubMed ID: 1249804
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and some pharmacological properties of oxytocin analogues having L-thiazolidine-4-carboxylic acid in position 7.
Rosamond JD; Ferger MF
J Med Chem; 1976 Jul; 19(7):873-6. PubMed ID: 940106
[TBL] [Abstract][Full Text] [Related]
15. Design of potent antagonists of the vasopressor response to arginine-vasopressin.
Bankowski K; Manning M; Haldar J; Sawyer WH
J Med Chem; 1978 Sep; 21(9):850-3. PubMed ID: 722751
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of peptides by fragment condensation on a solid support. II. A scheme for preparation of 4,8-disubstituted vasopressins evaluated on 8-arginine-vasopressin.
Larsson LE; Melin P; Ragnarsson U
Int J Pept Protein Res; 1976; 8(1):39-44. PubMed ID: 1248925
[TBL] [Abstract][Full Text] [Related]
17. Synthetic metabolites of neurohypophyseal hormones. (Des-9-glycinamide)oxytocin and (des-9-glycinamide, des-8-leucine)oxytocin.
Walter R; Havran RT; Schwartz IL
J Med Chem; 1976 Feb; 19(2):328-30. PubMed ID: 1249815
[TBL] [Abstract][Full Text] [Related]
18. Biofunctional evaluation of a hydrogen bond linking the ring and tail beta-turns of oxytocin.
Roy J; Roy U; Gazis DC; Schwartz IL
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3309-13. PubMed ID: 291004
[TBL] [Abstract][Full Text] [Related]
19. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid),2-D-isoleucine,4- valine]arginine-vasopressin at position 4.
Manning M; Nawrocka E; Misicka A; Olma A; Klis WA; Seto J; Sawyer WH
J Med Chem; 1984 Apr; 27(4):423-9. PubMed ID: 6708045
[TBL] [Abstract][Full Text] [Related]
20. Analogs of arginine vasopressin modified in position 3 with (R)-alpha-hydroxymethylphenylalanine.
Lempicka E; Slaninova J; Olma A; Lammek B
J Pept Res; 1999 May; 53(5):554-9. PubMed ID: 10424351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
